Literature DB >> 18443259

Persistent hot flushes in older postmenopausal women.

Alison J Huang1, Deborah Grady, Vanessa L Jacoby, Terri L Blackwell, Douglas C Bauer, George F Sawaya.   

Abstract

OBJECTIVE: To examine the prevalence, natural history, and predictors of hot flushes in older postmenopausal women.
METHODS: Prevalence, severity, and 3-year change in severity of hot flushes were assessed by questionnaire in 3167 older postmenopausal women with osteoporosis. Logistic regression was used to identify characteristics associated with symptoms at baseline and after 3 years of follow-up.
RESULTS: At baseline, 375 women (11.8%) reported bothersome hot flushes. Women were more likely to have baseline symptoms if they were less educated (odds ratio [OR], 1.28; 95% confidence interval [CI], 1.06-1.53 per 4-year decrease), more recently menopausal (OR, 1.44; 95% CI, 1.34-1.56 per 5-year decrease), had previously used estrogen (OR, 1.57; 95% CI, 1.23-2.00), or had undergone hysterectomy (OR, 1.51; 95% CI, 1.14-1.99). Hot flushes were also associated with higher body mass index (OR, 1.22; 95% CI, 1.08-1.38 per 1 SD), higher follicle-stimulating hormone levels (OR, 1.34; 95% CI, 1.20-1.51 per 1 SD), lower high-density lipoprotein levels (OR, 1.17; 95% CI, 1.03-1.34 per 1 SD decrease), vaginal dryness (OR, 1.52; 95% CI, 1.19-1.93), and trouble sleeping (OR, 2.48; 95% CI, 1.94-3.16), but not estradiol levels. Of the 375 women with baseline symptoms, 278 contributed 3-year data, and 157 (56.5%) of these women reported persistent symptoms after 3 years. Fewer years since menopause (OR, 1.15; 95% CI, 1.01-1.32 per 5-year decrease) and trouble sleeping (OR, 1.97; 95% CI, 1.19-3.26) were associated with symptom persistence.
CONCLUSIONS: For a substantial minority of women, hot flushes are a persistent source of discomfort into the late postmenopausal years. Identification of risk factors for hot flushes may help guide evaluation and treatment in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443259     DOI: 10.1001/archinte.168.8.840

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  18 in total

1.  Sleep and menopause.

Authors:  Sara Nowakowski; Charles J Meliska; L Fernando Martinez; Barbara L Parry
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

2.  Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women.

Authors:  Alison J Huang; Steven E Gregorich; Miriam Kuppermann; Sanae Nakagawa; Stephen K Van Den Eeden; Jeanette S Brown; Holly E Richter; Louise C Walter; David Thom; Anita L Stewart
Journal:  Menopause       Date:  2015-02       Impact factor: 2.953

3.  Predictors of vasomotor symptoms among breast cancer survivors.

Authors:  Katherine W Reeves; Michael Pennell; Randi E Foraker; Carolyn J Crandall; Marcia Stefanick; Electra D Paskett
Journal:  J Cancer Surviv       Date:  2018-02-09       Impact factor: 4.442

4.  Vasomotor symptoms and cardiovascular events in postmenopausal women.

Authors:  Emily D Szmuilowicz; JoAnn E Manson; Jacques E Rossouw; Barbara V Howard; Karen L Margolis; Nancy C Greep; Robert G Brzyski; Marcia L Stefanick; Mary Jo O'Sullivan; Chunyuan Wu; Matthew Allison; Diederick E Grobbee; Karen C Johnson; Judith K Ockene; Beatriz L Rodriguez; Gloria E Sarto; Mara Z Vitolins; Ellen W Seely
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

5.  The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women.

Authors:  Alison J Huang; Janis Luft; Deborah Grady; Miriam Kuppermann
Journal:  J Gen Intern Med       Date:  2009-11-12       Impact factor: 5.128

6.  Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer.

Authors:  Jennifer Gjerde; Jürgen Geisler; Steinar Lundgren; Dagfinn Ekse; Jan Erik Varhaug; Gunnar Mellgren; Vidar M Steen; Ernst A Lien
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

7.  Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study.

Authors:  Rebecca C Thurston; Kim Sutton-Tyrrell; Susan A Everson-Rose; Rachel Hess; Karen A Matthews
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

8.  Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors.

Authors:  Alison J Huang; Elya E Moore; Edward J Boyko; Delia Scholes; Feng Lin; Eric Vittinghoff; Stephan D Fihn
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

9.  Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy.

Authors:  Julie L Otte; David Flockhart; Daniel Hayes; Anna Maria Storniolo; Vered Stearns; Bryan Schneider; N Lynn Henry; Faouzi Azzouz; Anne Nguyen; Suzanne Lemler; Jill Hayden; Stacie Jeter; Laurie Wright; Janet S Carpenter
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

10.  Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial.

Authors:  Alison J Huang; Steven R Cummings; Michael Schembri; Eric Vittinghoff; Peter Ganz; Deborah Grady
Journal:  Menopause       Date:  2016-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.